High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $76.8 Billion
- Q2 2025
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 55,876 shares of NEPH stock, worth $239,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,876
Previous 55,710
0.3%
Holding current value
$239,149
Previous $95,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NEPH
# of Institutions
21Shares Held
4.38MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.61MShares$15.4 Million4.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA323KShares$1.38 Million0.0% of portfolio
-
Bard Associates Inc Chicago, IL131KShares$561,1970.2% of portfolio
-
Geode Capital Management, LLC Boston, MA93.2KShares$398,8400.0% of portfolio
-
Blair William & CO Chicago, IL36.2KShares$155,1450.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $44.2M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...